Klin Farmakol Farm. 2011;25(1):41-44

Treatment of migraine during pregnancy

Jolana Marková1, Alena Linhartová2
1 Neurologická klinika FTNsP, Praha
2 Nemocniční lékárna FTNsP, Praha

Primary headache disorders, particularly migraine and tension headaches, are very common in women in the childbearing age. The

article deals with a specific situation of women with migraine during the period of pregnancy when the development and progression

of various types of headache disorders is affected by the hormonal situation of the organism.

Most studies as well as the clinical practice confirm that in about 70 % of female migraine sufferers their migraine improves, particularly during

the second and third trimesters. This observation applies to migraine without aura. Women with migraine with aura more frequently suffer

from attacks in pregnancy as well. If the first migraine attack occurs no sooner than during pregnancy, it typically is migraine with aura. In

that case, it is necessary to rule out some of the secondary headache disorders, such as cerebral venous thrombosis, another cerebrovascular

accident or incipient eclampsia. There is no evidence that migraine with aura or without aura has any negative impact on the fetus.

The use of medications in pregnancy always means balancing between benefit and risk; therefore, the administration of each medication

should be considered carefully. Thus, the second part of the article deals with the safety issues of the use of selected medications or

medication groups in treating acute migraine attacks and, partially, with the use of medications in a prophylactic regimen.

Keywords: migraine, pregnancy, acute medications in pregnancy, prophylactic medications in pregnancy

Published: March 18, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marková J, Linhartová A. Treatment of migraine during pregnancy. Klin Farmakol Farm. 2011;25(1):41-44.
Download citation

References

  1. Mastík, J. Migréna, průvodce ošetřujícího lékaře. Maxdorf 2008: 104.
  2. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med 2005; 118(suppl 1): 3S-10S. Go to original source... Go to PubMed...
  3. Marková J. Bolesti hlavy. Triton, Praha 2007, 2. vydání, 77 str.
  4. Marcus DA. Managing headache during pregnancy and lactation. Expert Rev. Neurotherapeutics 2008; 8(3): 385-395. Go to original source... Go to PubMed...
  5. Wainscott G, Sullivan FM, Volans GN, Wilkinson M. The outcome of pregnancy in women suffering from migraine. Postgrad Med J 1978; 54: 98-102. Go to original source... Go to PubMed...
  6. Menon R, Bushnell CD. Headache and Pregnancy. The Neurologist. 2008; 14(2): 108-119. Go to original source... Go to PubMed...
  7. Loder E. Migraine in pregnancy. Seminars in Neurology 2007; 27(5): 426-431. Go to original source... Go to PubMed...
  8. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 5. vyd. Baltimore: WILLIAMS & WILKINS, 1998. ISBN 0-68330262-0.
  9. Micromedex(R) Healthcare Series: Reprorisk(R) System, (electronic version) [online]. [cit. 2008-03-12 a 2010-01-23]. Dostupné z: <http://www.thomsonhc.com>.
  10. Suchopár J. Léky v těhotenství. Praha: PANAX, 2000. ISBN 80-902806-1-7.
  11. Reiff-Eldridge R, Heffner CR, Ephross SA, Tennis PS, White AD, Andrews SB. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. Am J Obstet Gynecol. 2000; 182: 159-163. Go to original source... Go to PubMed...
  12. Goadsby PJ, Goldberg J, Silberstein SD. The pregnant migraineur: what can be done: Br Med J 2008; 336: 1502-1504. Go to original source... Go to PubMed...
  13. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS. EFNS guidelines on the drug treatment of migraine - revised report of an EFNS taks force. Europ J Neurol 2009; 16: 968-981. Go to original source... Go to PubMed...
  14. Evans EW, Lorber KC. Use of 5-HT1 agonists in pregnancy. Ann Pharmacother. 2008; 42(4): 543-549. Go to original source... Go to PubMed...
  15. Sumatriptan and naratriptan pregnancy registry: Interim report 1 January 1996-20 April 2007, http://pregnancyregistry.gsk.com/documents/sum_report_spring2007.pdf.
  16. Firemní literatura (SPC monokomponentních léčivých přípravků obsahujících jmenované účinné látky).




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.